Constance Thibault

4PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 26, 2026
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

|Feb 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Nadine Houédé, Thierry Chevallier, François Audenet

|Jun 28, 2023
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices.

Emmanuel Deshayes, Cyril Fersing, Constance Thibault

|Aug 05, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva

Pageof 1

Frequent Collaborators

3 joint publications

François Audenet

3 joint publications

Gwenaelle Gravis

2 joint publications

Yohann Loriot

1 joint publications

Anne-Gaëlle Goubet